Biotricity, Inc.
BTCY
$0.52
-$0.0099-1.87%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 14.09% | 13.55% | 15.47% | 25.15% | 28.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.09% | 13.55% | 15.47% | 25.15% | 28.55% |
| Cost of Revenue | -15.00% | -21.21% | -23.01% | -11.67% | 8.42% |
| Gross Profit | 29.40% | 35.17% | 43.52% | 53.55% | 42.46% |
| SG&A Expenses | -14.59% | -18.12% | -15.56% | -17.08% | -24.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.19% | -19.81% | -18.02% | -16.60% | -18.81% |
| Operating Income | 49.79% | 51.24% | 44.06% | 42.71% | 44.53% |
| Income Before Tax | 26.85% | 24.83% | 16.88% | 24.46% | 25.58% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 26.85% | 24.83% | 16.88% | 24.46% | 25.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.85% | 24.83% | 16.88% | 24.46% | 25.58% |
| EBIT | 49.79% | 51.24% | 44.06% | 42.71% | 44.53% |
| EBITDA | 49.83% | 51.27% | 44.08% | 42.73% | 44.55% |
| EPS Basic | 37.97% | 29.97% | 16.55% | 26.50% | 27.44% |
| Normalized Basic EPS | 42.55% | 34.72% | 21.00% | 19.62% | 28.57% |
| EPS Diluted | 37.97% | 29.97% | 16.55% | 26.50% | 27.44% |
| Normalized Diluted EPS | 42.55% | 34.72% | 21.00% | 19.62% | 28.57% |
| Average Basic Shares Outstanding | 99.48% | 57.51% | 18.86% | 3.83% | 2.70% |
| Average Diluted Shares Outstanding | 99.48% | 57.51% | 18.86% | 3.83% | 2.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.37% | 0.87% | 0.93% | 0.98% | 0.97% |
